Research Paper Volume 14, Issue 24 pp 10050—10066
SGOL2 promotes prostate cancer progression by inhibiting RAB1A ubiquitination
Figure 2. The construction of the shSGOL2 model was evaluated in prostate cancer cell lines. (A) Expression level of SGOL2 was detected in normal prostate cell lines and prostate cancer cell lines by qRT-PCR. (B) Efficiency of SGOL2 knockdown was accessed by WB in different cell lines. (C) Efficiency of SGOL2 knockdown was examined by WB in DU145 and LNCaP. (D) The fluorescence intensity and morphology of infected cells were observed in DU145 and LNCaP.